Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

No reported Accumulated OCI figures are available to summarize.

Accumulated OCI history

Currency unavailable · from the balance sheet

No Accumulated OCI data reported for this period type.

Accumulated OCI vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Accumulated OCI for KARD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NAMSNewAmsterdam Pharma Company N.V.Jun 2026$3.86M USD-10.8%+2.7%0.5%
RNAAtrium Therapeutics, Inc.Mar 2026$0 USD——0.0%
TNYATenaya Therapeutics, Inc.Mar 2026$0 USD+100.0%—0.0%
IKTInhibikase Therapeutics, Inc.Mar 2026-$26.29K USD-2619.0%-40.7%0.0%
CYTKCytokinetics, IncorporatedJun 2026-$3.83M USD-2321.5%—0.2%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —-1166.1%-19.0%0.0%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.